Skip to main content

CORRECTION article

Front. Oncol., 22 March 2021
Sec. Molecular and Cellular Oncology
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.675806

Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide

This article is a correction to:

  1. Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide

    1. Read original article
Monserrat Llaguno-Munive,Monserrat Llaguno-Munive1,2Sebastin Len-ZetinaSebastián León-Zetina1Ins Vazquez-LopezInés Vazquez-Lopez1María del Pilar Ramos-GodinezMaría del Pilar Ramos-Godinez3Luis A. Medina,Luis A. Medina4,5Patricia Garcia-Lopez*Patricia Garcia-Lopez1*
  • 1Laboratorio de Farmacología, Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico
  • 2Posgrado en Ciencias Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico
  • 3Departamento de Patología Quirúrgica, Instituto Nacional de Cancerología, Mexico City, Mexico
  • 4Unidad de Investigación Biomédica en Cáncer INCan-UNAM, Instituto Nacional de Cancerología, Mexico City, Mexico
  • 5Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico

A Corrigendum on
Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide

By Llaguno-Munive M, León-Zetina S, Vazquez-Lopez I, Ramos-Godinez MP, Medina LA and Garcia-Lopez P (2020). Front. Oncol. 10:581814. doi: 10.3389/fonc.2020.581814

In the original article, there was a mistake in Figure 2. Wrong microscopy photographs were included in the Sham and Mif/Tz 3-week groups. The corrected Figure 2 appears below.

FIGURE 2
www.frontiersin.org

Figure 2 Hematoxylin and eosin (H&E) staining analysis of glioma tissue. Hyperbasophilic cells (black arrow), hyperchromatics cells (red arrow), vessel proliferation (arrowhead), mitosis (blue arrow). The images are representative of three animals per treatment Scale bars = 50 mm.

The authors apologize for this mistake and state that this does not change the article’s scientific discussion and conclusions in any way. The original article has been updated.

Keywords: glioblastoma, temozolomide, mifepristone, drug resistance, angiogenesis, P-gp

Citation: Llaguno-Munive M, León-Zetina S, Vazquez-Lopez I, Ramos-Godinez MdP, Medina LA and Garcia-Lopez P (2021) Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide. Front. Oncol. 11:675806. doi: 10.3389/fonc.2021.675806

Received: 03 March 2021; Accepted: 04 March 2021;
Published: 22 March 2021.

Copyright © 2021 Llaguno-Munive, León-Zetina, Vazquez-Lopez, Ramos-Godinez, Medina and Garcia-Lopez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Patricia Garcia-Lopez, pgarcia_lopez@yahoo.com.mx

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.